COMMUNIQUÉS West-GlobeNewswire

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

18/01/2019 - 12:30

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, Jan. 18, 2019 (GLOBE NEWSWIRE) -- [...]

CorVel Announces Promotion of Michael Combs to Chief Executive Officer

18/01/2019 - 12:15

IRVINE, Calif., Jan. 18, 2019 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), announced today that its Board of Directors has promoted the Company’s President, Michael Combs, to also serve as its Chief Executive [...]

Digirad Corporation Announces Appointment of Mitchell I. Quain to its Board of Directors

18/01/2019 - 12:00

SUWANEE, Ga., Jan. 18, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) announced today the appointment of Mitchell I. Quain, 67, as a new independent director to its Board of Directors, effective immediately [...]

111, Inc. Announces Management and Board Changes

18/01/2019 - 10:30

SHANGHAI, China, Jan. 18, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading integrated online and offline healthcare platform in China, today announced that Mr. Weihao Xu has resigned [...]

Biohit new-generation fecal immunochemical test (ColonView-FIT) is superior to traditional guaiac test in colorectal cancer screening

18/01/2019 - 08:30

Biohit Oyj Press release 18.01.2019 at 9.30 local time (EEST) Biohit ColonView test is a new-generation fecal immunochemical test (FIT) designed for detection of fecal occult blood (FOB) in subjects participating in [...]

Correction: Managers’ transactions

18/01/2019 - 08:11

Company announcement no.02/2019 Correction: Purchase of shares in Chr. Hansen Holding A/S For further information, please contact: Martin Riise, Head of Investor Relations, Tel: +45 53 39 22 50 Camilla Lercke, Head of [...]

Xbrane Biopharma announces acceptance of initiation of Xlucane clinical trial in the US

18/01/2019 - 08:01

Press release 2019-01-18 The Food and Drug Administration (FDA) and the Central Ethics Committee in the United States have accepted Xbranes IND application for initiation of the Xplore trial, a phase III trial with [...]

Managers’ transactions

18/01/2019 - 07:22

Company announcement no.02/2019 For further information, please contact: Martin Riise, Head of Investor Relations, Tel: +45 53 39 22 50 Camilla Lercke, Head of Media Relations, Tel: +45 53 39 23 84 About Chr. Hansen Chr [...]

Bavarian Nordic Announces Exercise of USD 44 Million Option by the U.S. Government under Contract for Freeze-dried MVA-BN® Smallpox Vaccine

18/01/2019 - 07:16

COPENHAGEN, Denmark, January 18, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA) have exercised another option under the [...]

ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting

18/01/2019 - 07:00

LYON, France and CAMBRIDGE, Mass., Jan. 18, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug [...]

ERYTECH présente un poster sur l’étude en cours TRYbeCA-1 lors de la conférence annuelle ASCO-GI 2019

18/01/2019 - 07:00

LYON, France et CAMBRIDGE, Mass., 18 janv. 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris : ERYP Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant [...]

Sunesis Announces Pricing of $20 Million Offering of Securities

18/01/2019 - 03:58

SOUTH SAN FRANCISCO, Calif., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) today announced the pricing of underwritten public offerings of (i) 23,000,000 shares of its common stock and ( [...]

Immunomedics Receives Complete Response Letter From FDA for Sacituzumab Govitecan Biologics License Application

18/01/2019 - 02:12

MORRIS PLAINS, N.J., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]

Sanofi: FDA advisory committee votes on Zynquista(TM) (sotagliflozin) as treatment for adults with type 1 diabetes

18/01/2019 - 00:20

FDA advisory committee votes on Zynquista(TM) (sotagliflozin) as treatment for adults with type 1 diabetes PARIS and THE WOODLANDS, TX - January 17, 2019 - The Endocrinologic and Metabolic Drugs Advisory Committee of [...]

Sanofi : Le comité consultatif de la FDA se prononce sur ZynquistaTM (sotagliflozin) dans le traitement du diabète de type 1 de l'adulte

18/01/2019 - 00:20

Le comité consultatif de la FDA se prononce sur Zynquista TM (sotagliflozin) dans le traitement du diabète de type 1 de l'adulte PARIS et THE WOODLANDS (TEXAS) - Le 17 janvier 2019 - Le Comité consultatif des [...]

Lexicon Pharmaceuticals to Host Conference Call and Webcast on January 17, 2019 to Discuss Outcome of FDA Advisory Committee Meeting for Sotagliflozin in Type 1 Diabetes

18/01/2019 - 00:20

THE WOODLANDS, Texas, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that management will conduct a conference call and live webcast on Thursday, January 17, 2019, at 7:00 [...]

FDA Advisory Committee Votes on Zynquista™ (sotagliflozin) as Treatment for Adults With Type 1 Diabetes

18/01/2019 - 00:20

PARIS and THE WOODLANDS, Texas, Jan. 17, 2019 (GLOBE NEWSWIRE) -- The Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) today voted eight to eight on the question of [...]

Chembio Diagnostics Announces 2019 Analyst and Investor Meeting

17/01/2019 - 22:10

MEDFORD, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will host an analyst and [...]

Bio-Path Holdings, Inc. Announces Closing of Public Offering of Common Stock

17/01/2019 - 22:07

HOUSTON, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio [...]